COPD is associated with increased cardiovascular disease risk independent of phenotype
COPD ist mit einem erhöhten Risiko für kardiovaskuläre Erkrankungen unabhängig vom Phänotyp assoziiert
Respirology · 2024-12 · 29 (12) · 1047-1057
DOI: 10.1111/resp.14799 ↗Auf einen Blick
In einer national repräsentativen Analyse hatten Menschen mit COPD häufiger kardiovaskuläre Erkrankungen. Das Risiko war bei allen Phänotypen erhöht, am stärksten bei gleichzeitigem chronischem Bronchitis- und Emphysem-Phänotyp.
Fragestellung
Wie ist das kardiovaskuläre Erkrankungsrisiko bei COPD insgesamt und nach Phänotyp im Vergleich zu Personen ohne COPD?
Methode
Auswertung von NHANES-Daten aus 1999–2018 mit 31.560 Erwachsenen, davon 2.504 mit COPD.
Ergebnisse
Kardiovaskuläre Erkrankungen waren bei COPD in allen Phänotypen häufiger. Gegenüber ohne COPD betrugen die Odds Ratios 1,76 (95 %-KI 1,41–2,20) für chronische Bronchitis, 2,31 (95 %-KI 1,80–2,96) für Emphysem und 2,98 (95 %-KI 2,11–4,21) für den kombinierten Phänotyp.
Schlussfolgerung der Autor:innen
Die Daten bestätigen ein erhöhtes Risiko für kardiovaskuläre Erkrankungen bei COPD in allen Phänotypen, am stärksten beim gleichzeitigen Vorliegen von chronischer Bronchitis und Emphysem.
Kernaussagen
- COPD war mit mehr kardiovaskulären Erkrankungen assoziiert
- Am stärksten erhöht war das Risiko beim kombinierten Phänotyp
- Die Autoren betonen die Bedeutung von Aufmerksamkeit und kardiovaskulärem Screening
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
At a glance
Journal article in Respirology, published online on 2024-07-17. Written by Kolton Cobb and 7 co-authors. Institution: Department of Kinesiology and Health Sciences, Virginia Commonwealth University, Richmond, Virginia, USA. Major MEDLINE topics: Pulmonary Disease, Chronic Obstructive, Phenotype, Cardiovascular Diseases, Nutrition Surveys. Cited 35 times so far (Crossref); 58 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Institute on Drug Abuse of the National Institutes of Health and the Center for Tobacco Products of the U.S. Food and Drug Administration, NCATS NIH HHS, National Center for Advancing Translational Sciences and the CCTR Endowment Fund of Virginia Commonwealth University.
Topics: COPD
Abstract (original language)
Background and Objective Chronic obstructive pulmonary disease (COPD) is a leading cause of death worldwide that frequently presents with concomitant cardiovascular diseases. Despite the pathological distinction between individual COPD phenotypes such as emphysema and chronic bronchitis, there is a lack of knowledge about the impact of COPD phenotype on cardiovascular disease risk. Thus, this study aimed to utilize a nationally representative sample to investigate cardiovascular disease prevalence in patients with COPD with emphysema and chronic bronchitis phenotypes.
Methods
Data from 31,560 adults including 2504 individuals with COPD, collected as part of the National Health and Nutrition Examination Survey (1999–2018), were examined.
Results
A significantly increased cardiovascular disease risk, including coronary heart disease, heart failure, myocardial infarction and stroke, was identified in patients with COPD among all disease phenotypes. Particularly, compared to those without COPD, individuals with chronic bronchitis presented with 1.76 (95% CI: 1.41–2.20) times greater odds, individuals with emphysema with 2.31 (95% CI: 1.80–2.96) times greater odds, while those with a concurrent phenotype (combined chronic bronchitis and emphysema) exhibited 2.98 (95% CI: 2.11–4.21) times greater odds of reporting cardiovascular diseases.
Conclusion
Our data confirms that patients with COPD present an elevated risk of developing cardiovascular disease among all phenotypes, with the most marked increase being in those with concurrent chronic bronchitis and emphysema phenotypes. These findings emphasize the need for awareness and appropriate cardiovascular screening in COPD. image
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Kinesiology and Health Sciences, Virginia Commonwealth University, Richmond, Virginia, USA.
- Division of Epidemiology, Virginia Commonwealth University, Richmond, Virginia, USA.
- Division of Pulmonary and Critical Care, Virginia Commonwealth University, Richmond, Virginia, USA.
ORCID profiles: Benjamin Krieger
Funding
- National Institute on Drug Abuse of the National Institutes of Health and the Center for Tobacco Products of the U.S. Food and Drug Administration
- NCATS NIH HHS
- National Center for Advancing Translational Sciences and the CCTR Endowment Fund of Virginia Commonwealth University
- NIDA NIH HHS
- Child Health Research Institute of Children's Hospital of Richmond at Virginia Commonwealth University
- American Heart Association
- Virginia Commonwealth University School of Medicine Dean's Summer Fellowship
Cite
APA
Cobb, K., Kenyon, J., Lu, J., Krieger, B., Perelas, A., Nana-Sinkam, P., Kim, Y., & Rodriguez-Miguelez, P. (2024). COPD is associated with increased cardiovascular disease risk independent of phenotype. Respirology, 29(12), 1047-1057. https://doi.org/10.1111/resp.14799
Vancouver
Cobb K, Kenyon J, Lu J, Krieger B, Perelas A, Nana-Sinkam P, et al. COPD is associated with increased cardiovascular disease risk independent of phenotype. Respirology. 2024;29(12):1047-1057. doi:10.1111/resp.14799
BibTeX
@article{Cobb2024,
author = {Cobb, Kolton and Kenyon, Jonathan and Lu, Juan and Krieger, Benjamin and Perelas, Apostolos and Nana-Sinkam, Patrick and Kim, Youngdeok and Rodriguez-Miguelez, Paula},
title = {COPD is associated with increased cardiovascular disease risk independent of phenotype},
journal = {Respirology},
year = {2024},
volume = {29},
number = {12},
pages = {1047--1057},
doi = {10.1111/resp.14799}
}
EUVIMED